BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30785120)

  • 1. Pseudoxanthomatous or xanthelasmoid mastocytosis: Reporting a rare entity.
    Sinha P; Sandhu S; Sen A; Sood A
    Indian J Dermatol Venereol Leprol; 2020; 86(4):382-385. PubMed ID: 30785120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation of telangiectasia macularis eruptiva perstans as a long-standing solitary plaque associated with renal carcinoma.
    Pascual JC; Bañuls J; Albares MP; Vergara G; Belinchón I; Silvestre JF; Betlloch I
    J Cutan Med Surg; 2003; 7(5):399-402. PubMed ID: 14973646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Xanthelasmoid mastocytosis: a rare form of cutaneous mastocytosis].
    Ramid H; Hali F
    Pan Afr Med J; 2017; 28():104. PubMed ID: 29515722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cutaneous Manifestations in Mastocytosis: Update].
    Ferreira S; Fernandes I; Cabral R; Machado S; Lima M; Selores M
    Acta Med Port; 2020 Apr; 33(4):275-281. PubMed ID: 32238242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of telangiectasia macularis eruptiva perstans with montelukast.
    Cengizlier R; Hücümenoğlu S; Ozen A; Tülin Sayli R
    Allergol Immunopathol (Madr); 2009; 37(6):334-6. PubMed ID: 19913347
    [No Abstract]   [Full Text] [Related]  

  • 6. Scarring alopecia associated with mastocytosis.
    Xu X; Solky B; Elenitsas R; Cotsarelis G
    J Cutan Pathol; 2003 Oct; 30(9):561-5. PubMed ID: 14507404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Telangiectasia macularis eruptiva perstans, a form of cutaneous mastocytosis, associated with malignant melanoma.
    Kowalzic L; Eickenscheidt L; Seidel C; Kribus S; Ziegler H; Komar M
    J Dtsch Dermatol Ges; 2009 Apr; 7(4):360-2. PubMed ID: 19054427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous mastocytosis: a review focusing on the pediatric population.
    Briley LD; Phillips CM
    Clin Pediatr (Phila); 2008 Oct; 47(8):757-61. PubMed ID: 18502981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Telangiectasia Macularis Eruptiva Perstans Revisited.
    Heymann WR
    Skinmed; 2017; 15(4):287-288. PubMed ID: 28859740
    [No Abstract]   [Full Text] [Related]  

  • 10. [Diffuse cutaneous mastocytosis of an infant: A case report].
    Zaouri H; Amarouch H; Elmakrini N; Tazi N; Ismaili N; Benzekri L; Senouci K; Hassam B
    Arch Pediatr; 2016 Nov; 23(11):1150-1152. PubMed ID: 27670724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Telangiectatic mastocytosis versus telangiectasia macularis eruptiva perstans.
    Urbina F
    J Dermatol; 2019 Mar; 46(3):e96-e97. PubMed ID: 30144139
    [No Abstract]   [Full Text] [Related]  

  • 12. Plane xanthoma associated with multiple mastocytoma.
    Matsumoto M; Ikeda M; Takeya M; Kodama H
    Pediatr Dermatol; 2007; 24(5):E66-9. PubMed ID: 17958784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bullous Mastocytosis: A Rare Variant of Diffuse Cutaneous Mastocytosis.
    Almheiri SK; Pakran J; AlFalasi AA; El Bahtimi R
    Cureus; 2024 Jan; 16(1):e51660. PubMed ID: 38313964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dermatoscopic findings of cutaneous mastocytosis.
    Akay BN; Kittler H; Sanli H; Harmankaya K; Anadolu R
    Dermatology; 2009; 218(3):226-30. PubMed ID: 19060465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of telangiectasia macularis eruptiva perstans demonstrated by immunohistochemistry for c-kit (CD 117).
    Lee HW; Jeong YI; Choi JC; Lee MW; Choi JH; Moon KC; Koh JK
    J Dermatol; 2005 Oct; 32(10):817-20. PubMed ID: 16361734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Most common clinical presentations of cutaneous mastocytosis.
    Bulat V; Mihić LL; Situm M; Buljan M; Blajić I; Pusić J
    Acta Clin Croat; 2009 Mar; 48(1):59-64. PubMed ID: 19623875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Telangiectasia Macularis Eruptiva Perstans: Report of Three Cases.
    Tumer G; Jow T; McElligott S; Schwartz RA; Lambert WC
    Skinmed; 2017; 15(3):171-174. PubMed ID: 28705275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telangiectasia macularis eruptiva perstans: an old terminology, still frequently used.
    Wilmas K; Wohlmuth-Wieser I; Duvic M
    Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual cutaneous findings of urticaria pigmentosa and telangiectasia macularis eruptiva perstans associated with marked myelofibrosis.
    Turchin I; Barankin B; Schloss E
    Int J Dermatol; 2006 Oct; 45(10):1215-7. PubMed ID: 17040445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.